News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Mergers and Acquisitions (World)
Roivant Acquires SB742457 From GlaxoSmithKline (GSK) 12/23/2014
Spending Spree Continues as Actavis (ACT) Considers Near $3 Billion Bid for Almirall 12/23/2014
AstraZeneca PLC (AZN) CEO Believes New Pfizer (PFE) Bid Unlikely 12/23/2014
Roche (RHHBY) To Pay Up To $489 Million For Next-Gen Antibody Firm Dutalys 12/22/2014
Shire (SHPGY) May Spend AbbVie (ABBV) Breakup Fee On NPS Pharmaceuticals, Inc. (NPSP); NPS Surges On Rumor 12/19/2014
KCR Acquires Project Portfolio From Ukrainian CRO AXIS 12/18/2014
RedHill Biopharma Ltd. (RDHL) Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn's Program 12/18/2014
UCB SA Terminates $1.53 Billion Sale Of Generic Drug Unit To Buyout Firms 12/17/2014
Evolva A/S Unloads EV-035 Series To Emergent BioSolutions (EBS) For $70.5 Million Plus 12/17/2014
Novartis AG (NVS) Takes Stake In Israeli Biopharma BioLine; Makes $10 Million Investment 12/16/2014
Renmatix Acquires Sweden-Based REAC Fuel's Intellectual Property 12/16/2014
Sosei Group Corporation Acquires Jitsubo, A Leading Japanese Peptide Technology Company 12/12/2014
Cipla Ltd. Sells Stake In Jiangsu Cdymax Pharma For $18.5 Million 12/12/2014
Interim CEO Says Sanofi (SAN.PA) Continuing Diversification, Eyeing Acquisitions 12/10/2014
China, South Korea OK GlaxoSmithKline (GSK)'s $43B Covidien (COV) Buy 12/5/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
Forbion Announces Sale Of Portfolio Company PneumRx Inc. To BTG plc (BTG.L) For Up To EUR 385M (USD 475M) 12/4/2014
Roche (RHHBY) Acquires Ariosa Diagnostics, Inc. And Enters The Non-Invasive Prenatal Test (NIPT) And Cell-Free DNA Testing Services Markets 12/3/2014
Shanghai Fosun Buys 65% Stake In Suzhou Erye Pharma 12/3/2014
Alizé Acquires Exclusive Worldwide Rights On A New Peptide To Tackle Bone Diseases 12/3/2014
Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals (AVNR) For $3.5 Billion 12/2/2014
Pfizer (PFE) Announces Completion Of Merger With Wyeth 12/2/2014
Contera Pharma Announces Acquisition By Korean Bukwang Pharmaceutical 12/1/2014
Imaflex Acquires Controlled-Release Agricultural Mulch Film Assets From Bayer AG (BAYZF) 12/1/2014
European Commission (EC) Regulators Mull Novartis AG (NVS), GlaxoSmithKline (GSK) Deals As January Deadline Looms 12/1/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
AbbVie (ABBV) Acquires Manufacturing Facility In Singapore; Further Expands Capabilities In Asia 11/21/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Jubilant Life Sciences (JOL) Seeks To Complete Buyout Of U.S.-Based Cadista For Up To $33.2 Million 11/14/2014
PE Firm To Bid For GlaxoSmithKline (GSK)'s $3 Billion Mature Drugs Portfolio 11/14/2014
Recipharm AB Bags Lusomedicamenta For $140 Million 11/14/2014
Sanofi (SAN.PA) Unloads Large Office In India 11/13/2014
Nuvo Research Inc. (NRI.TO) Reacquires Pennsaid® 2% Rights To South America, Central America, South Africa And Israel 11/13/2014
Thailand-Based SCG Acquires Stake In Liechtenstein-Based Research Company Lysando AG 11/12/2014
AstraZeneca PLC (AZN) Is Building Value Without Pfizer (PFE): CEO 11/11/2014
Johnson & Johnson (JNJ) Chief Eyes Acquisitions In China 11/10/2014
UCB Group (UCBJF.PK) Divests U.S. Generics Unit For $1.53 Billion 11/7/2014
GVK BIO Signs Definitive Agreement To Acquire Vanta Bioscience 11/6/2014
Perrigo Company (PRGO) Snatches Up Omega Pharma NV (0OMEP.BR) For $4.5 Billion 11/6/2014
Univar Expands in Brazil Market With Acquisition Of D'Altomare Quimica Ltda. 11/4/2014
Taiyo Pacific Partners Becomes Major Shareholder In Peptidream With Stake Over 5% 11/4/2014
AstraZeneca PLC (AZN) Builds Cancer Immunotherapy Capabilities With $150 Million Definiens AG Buy 11/4/2014
AbbVie (ABBV) Not Looking For Massive Deals After Abandoning Shire 11/3/2014
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014
Deal-Starved Perrigo Company (PRGO) In Exclusive Talks To Buy $5 Billion+ Omega Pharma NV (0OMEP.BR) 10/31/2014
Bayer AG (BAYZF) Hunts For More Deals After Bulking Up Consumer Care 10/30/2014
Novartis AG (NVS) Sells Flu Vaccine Business For $275 Million To CSL Limited (CMXHF.PK) 10/28/2014
Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma 10/28/2014
Zogenix, Inc. (ZGNX) Snags U.K.-Based Brabant Pharma In $35 Million Cash-Stock Deal 10/27/2014
Private Equity Eyes $13 Billion Bayer AG (BAYZF)'s Plastics Business 10/24/2014
Mylan Inc. (MYL), Abbott Laboratories (ABT) Tweak $5 Billion Tax Inversion Deal 10/23/2014
AbbVie (ABBV) Officially Abandons Shire 10/21/2014
Therapix Signs Non-Binding Agreement to Acquire Dekel Pharmaceuticals Ltd. 10/21/2014
Actavis (ACT) Will Compete With Sanofi (SAN.PA) For $5.1 Billion Omega Pharma NV (0OMEP.BR) Deal 10/21/2014
Lupin Ltd. (LUPN.BO) Scouts For Acquisitions In U.S. 10/21/2014
Shire Goes Shopping After AbbVie (ABBV) Deal Falls Through 10/21/2014
Fresenius AG, Buyout Groups Eye Danone Medical Nutrition Unit 10/20/2014
AbbVie (ABBV) Board Officially Abandons $55 Billion Shire Merger 10/17/2014
Virax To Acquire Deep AKT Inhibitor Portfolio Already In Phase 1b/2 Breast & Phase 1b Ovarian Cancer Trials 10/17/2014
Horizon Biopharm Pays $45 Million Cash For U.S. Rights To PENNSAID® 2% 10/17/2014
DiaGenic ASA: Completed Acquisition Of NEL Hydrogen – Company Name And Ticker To Be Changed 10/17/2014
Shire Plummets As AbbVie (ABBV) Reconsiders $55 Billion Takeover Bid 10/16/2014
Analysts Still See AstraZeneca PLC (AZN) As Viable Takeover Target 10/15/2014
Geographic Split Likely For GlaxoSmithKline (GSK) Mature Drugs Sale 10/15/2014
MorphoSys AG Acquires Lanthipeptide Technology From Lanthio Pharma 10/15/2014
Oxford BioMedica PLC (OXB.L) Acquires Windrush Court Office And Laboratory Facilities 10/13/2014
GlaxoSmithKline (GSK) Takes A 25% Stake In Aspen Pharmacare Ltd. Japanese Unit 10/9/2014
Endo International plc (ENDP) Pays $2.6 Billion For Auxilium Pharmaceuticals (AUXL), Auxilium Drops QLT Inc. (QLTI) Deal 10/9/2014
DiaGenic ASA Signed Final Agreement To Acquire NEL Hydrogen AS – Extended Announcement 10/8/2014
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/7/2014
Top Managers Argue Over What To Do With Sanofi (SAN.PA)'s $8 Billion Drug Portfolio 10/7/2014
Analyst Dismisses Teva Pharmaceutical Industries Limited (TEVA)-Mylan Inc. (MYL) Merger Rumor 10/7/2014
Week in Review: WuXi PharmaTech Co., Ltd. Acquires XenoBiotic Laboratories, Inc. , A US-China CRO 10/6/2014
Actavis (ACT) Finally Makes A Move, Pays $675 Million For Durata Therapeutics, Inc.  (DRTX) 10/6/2014
Salix Pharmaceuticals, Ltd. (SLXP) Linked With Actavis (ACT) After Calling Off Cosmo Pharmaceuticals S.p.A. Merger Amid Inversion Crackdown 10/3/2014
Immutep S.A. Picks Up Prima Biomed (PRR.AX) For $28 Million 10/2/2014
Prima Biomed (PRR.AX) Secures $37.4 Million To Fund Immutep S.A. Acquisition 10/2/2014
Consort Medical Scoops Up Aesica For $374 Million 10/1/2014
WuXi PharmaTech Co., Ltd. Laboratory Testing Division Expands In U.S. With Acquisition Of XenoBiotic Laboratories, Inc. 10/1/2014
Recipharm AB Completes Acquisition Of Corvette Pharmaceutical Services Group For SEK1.1 Billion 10/1/2014
Strides Arcolab Limited Snags Shasun Pharma In All Stock Deal Worth Over $221 Million 9/30/2014
Chiltern International Ltd. Acquires Pacific Clinical Research Pte Limited And Expands Operations And Therapeutic Depth In Asia-Pacific 9/29/2014
Daiichi Sankyo, Inc. (4568.t) Boosts Cancer Pipeline With $410 Million Ambit Biosciences Buy 9/29/2014
Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC 9/29/2014
Pfizer (PFE) Approached Actavis (ACT) For Possible Merger 9/24/2014
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL) 9/23/2014
Bionomics Limited (BNO.AX) Acquires Prestwick Chemical 9/23/2014
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer 9/17/2014
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014
ReproCELL Acquires The iPS Cell Business Unit Of Stemgent, Inc. 9/9/2014
Cellectis (ALCLS) Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio 9/4/2014
China Biologic Products Completes Transaction To Acquire Additional Equity Stake In Guizhou Taibang 9/4/2014
Mercachem Holding B.V. To Acquire Prague Business From Synthon 9/3/2014
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer (PFE) Bid; Start Of New Cancer Trial 9/2/2014
Luye Pharma Buys Majority Stake In Beijing Jialin For $599 Million 8/29/2014
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014
Novo Nordisk A/S (NVO) Prefers To Grow On Its Own, Not Buy Others: CEO 8/27/2014
Synexus Further Expands Its Global Footprint With An Acquisition In South Africa 8/27/2014
Disappointment Looms As Roche (RHHBY) Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) 8/26/2014
Roche (RHHBY) Pays $8.3 Billion For Bay Area's InterMune, Inc. (ITMN), Pledges To Keep Employees 8/26/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Pfizer (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN) 8/22/2014
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio 8/22/2014
DrugDev Acquires Award-Winning Trialnetworks Platform, Launches Innovation Lab, Unveils Investigator Databank Website And Reaches $1 Billion In Global Site Payments In First Half Of 2014 8/21/2014
Sweden's Recipharm AB Pays $160 Million For Corvette Pharmaceutical Services Group 8/19/2014
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal 8/19/2014
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/19/2014
Deal Is Back On: Novartis AG (NVS) To Invest Heavily In Gamida Cell Ltd. Before Acquisition 8/18/2014
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up 8/18/2014
Mallinckrodt Pharmaceuticals (MNK) Completes Acquisition Of Questcor Pharmaceuticals, Inc. (QCOR) 8/15/2014
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014
Merck KGaA (MKGAF.PK) CEO Eyes Interesting Takeover Targets 8/14/2014
SkyePharma Inc. (SKYE) Acquires A Novel Inhaled Therapy Platform 8/13/2014
uniQure Acquires Cardiology Gene Therapy Company InoCard 8/12/2014
Boehringer Ingelheim Vetmedica, Inc. Acquires Licensing Rights For Artilysin® Technology From Lysando AG 8/12/2014
Endo International plc (ENDP) Completes Acquisition Of DAVA Pharmaceuticals 8/7/2014
After Layoff News, Novartis AG (NVS)'s New York Campus Officially Goes On The Market 8/7/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
Analysts Believe Vulnerable GlaxoSmithKline (GSK) May Be Pfizer (PFE)'s Plan B 8/6/2014
Roche (RHHBY) Bags Santaris Pharma A/S In Deal Worth $450 Million 8/5/2014
Private Equity Firms Mull $10 Billion Merger Of Older GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Brands 8/4/2014
Hedge Funds Bet AstraZeneca PLC (AZN) Will Stay Independent For A Little While Longer 8/4/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 7/31/2014
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse 7/31/2014
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion 7/30/2014
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions 7/30/2014
Cellectis (ALCLS) Sells Its Swedish Unit To Takara Bio For Undisclosed Amount 7/29/2014
AbbVie (ABBV) Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker Shire 7/25/2014
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site 7/24/2014
Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina 7/21/2014
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions 7/21/2014
Novartis AG (NVS), BWK Sell Stakes In Patch Maker LTS Lohmann Therapie-Systeme AG, Pockets $400 Million From Sale 7/17/2014
Sanofi (France) (SAN.PA) Quietly Held Talks With Abbott Laboratories (ABT), Mylan Inc. (MYL) About Mature Drugs 7/17/2014
Yibai Pharma To Acquire Horus C&K Pharma For $128 Million 7/16/2014
Chiltern Acquires Ockham And The Companies Merge Operations 7/15/2014
Phlexglobal Announces Acquisition By Bridgepoint Development Capital 7/15/2014
Hikma Pharmaceuticals Completes The Acquisition Of Assets Of Bedford Laboratories 7/15/2014
BioTie Therapies Corp. Will Not Exercise Option To Buy Neurelis, Neurelis Regains Rights To Intranasal Diazepam Program 7/11/2014
Valeant Pharmaceuticals International (VRX) Completes Sale Of Filler And Toxin Assets To Galderma 7/10/2014
AbbVie (ABBV) Forced To Retract Claims Of Shire Investor Support 7/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Scoops Up Cosmo Technologies For Tax Savings 7/9/2014
$100 Million Triple Life Sciences Deal For Newly Formed Concept Life Sciences 7/8/2014
Valeant Pharmaceuticals International (VRX) Completes Acquisition Of PreCision Dermatology 7/8/2014
AbbVie (ABBV)'s Battle For Shire: Why This Time It's Different 7/8/2014
Xellia Pharmaceuticals Expands Into The U.S. With Manufacturing Plant Buy 7/7/2014
Medicure Inc. (MCU) Grabs Minority Position In Pharmaceutical Manufacturer, Apicore LLC 7/3/2014
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/3/2014
NicOx SA (COX.PA) Scoops Up Aciex Therapeutics In $120 Million Deal 7/2/2014
Cell Source Inc. Announces Acquisition And $3.6 Million Private Placement To Advance Novel Cancer Therapies 7/1/2014
AbbVie (ABBV) Takes Shire Courtship Trip To London 6/30/2014
Merz North America Pays $600 Million For Ultrasound Facelift Company Ulthera 6/30/2014
RedHill Biopharma Ltd. (RDHL) Acquires Phase 2 Oncology Drug MESUPRON® From Wilex AG (WL6.DE) 6/30/2014
Shire Entertained Many "Large Opportunities" Before AbbVie (ABBV) Bid 6/27/2014
Like GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Mulls Sale Of Older Drugs, Plans To Put Dengue Vaccine Program In Separate Unit 6/27/2014
Valeant Pharmaceuticals International (VRX) Files Preliminary Proxy Statement For Special Meeting Of Shareholders To Approve Share Issuance In Proposed Acquisition Of Allergan Inc. (AGN) 6/25/2014
Warnex Inc. (CC:WNX) Received TSX-V Approval And Waives Due Diligence Condition To Amalgamation With Diagnos Inc. (ADK) 6/25/2014
AbbVie (ABBV) Urges Talks With Shire, May Have To Raise Bid To $51 Billion 6/25/2014
Shire To Set Out AstraZeneca PLC (AZN)-Style Defense Against AbbVie (ABBV)'s $46 Billion Bid 6/24/2014
Endo Buys DAVA Pharmaceuticals For $575 Million 6/24/2014
H. Lundbeck A/S (LUN.CO) Completes Acquisition Of Chelsea Therapeutics, Inc. (CHTP) 6/24/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Tentative Election Deadline Of June 27, 2014 6/24/2014
Abbott Laboratories (ABT) Scoops Up Russian Drugmaker Veropharm For Between $395 To $495 Million Cash 6/24/2014
AbbVie (ABBV) Release: Shire Bid Could Move A Lot High Risk Puts Ceiling At £55/Share 6/23/2014
Lundbeck Inc. (LUN.CO) Successfully Completes Tender Offer For Chelsea Therapeutics, Inc. (CHTP) 6/23/2014
Shire plc Release: Management Spurns Three Offers From AbbVie (ABBV) , Fighting For Irish Independence, Call Monday Morning 6/23/2014
To Fend Off Pfizer Inc. (PFE), AstraZeneca PLC (AZN) Contemplating Sale Of Some Future Revenue From Existing Drugs 6/23/2014
Third Time Is Not The Charm As AbbVie (ABBV)'s $46 Billion Bid For Irish Rival Shire Rejected 6/23/2014
Rumor: Pfizer Inc. (PFE) May Be Interested In Buying Bristol-Myers Squibb Company (BMY) After Losing AstraZeneca PLC (AZN) 6/20/2014
While Valeant Pharmaceuticals International (VRX) Fights For Allergan Inc. (AGN), Allergan Takeover Bid For Shire "Imminent" 6/19/2014
New Drugs To Help Maintain Independence, Ward Off M&A Prospects: Actelion Ltd. (ALIOF.PK) CEO 6/19/2014
Trendlines Acquires Intellectual Property From Collaboration With Endo 6/18/2014
Irish-Based Shire Braces For Takeover Bids 6/18/2014
Pfizer Inc. (PFE) CFO Reveals Money Killed AstraZeneca PLC (AZN) Deal 6/16/2014
Commentary: BioSpace (DHX) Readers Sound Off On Big Pharma Takeovers 6/12/2014
Roche (RHHBY) Markets 5 Buildings On New Jersey Campus, Razing The Rest 6/11/2014
Chelsea Therapeutics, Inc. (CHTP) Announces The Expiration Of The Hart-Scott-Rodino Waiting Period In Relation To The Proposed Acquisition Of Chelsea Therapeutics By H. Lundbeck A/S (LUN.CO) 6/6/2014
Teva Pharmaceutical Industries Limited (TEVA) Buys Privately Held Labrys Biologics In Deal Worth $825 Million 6/4/2014
GlaxoSmithKline (GSK) Hunts For Suitors To Buy Older Drugs, Eyes Cash To Focus On Most Lucrative Areas Of Business 6/2/2014
Endo Completes Sale Of Early Stage Drug Discovery Portfolio 6/2/2014
TiGenix Completes The Sale Of Its Dutch Manufacturing Facility To PharmaCell BV 6/2/2014
Provence Technologies Acquires Synprosis 6/2/2014
Pfizer Inc. (PFE) Officially Ditches Pursuit Of AstraZeneca PLC (AZN) 5/29/2014
Sweden's Lund University Acquires Biomass Pretreatment Reactor From AdvanceBio Systems 5/27/2014
Recordati S.p.A Finalizes The Second Tranche Of Its Acquisition Of Opalia Pharma In Tunisia 5/27/2014
Loophole Offers Pfizer Inc. (PFE) A Risky Way Back Into A Deal With AstraZeneca PLC (AZN) 5/23/2014
H. Lundbeck A/S (LUN.CO) Commences Tender Offer For All Outstanding Shares Of Chelsea Therapeutics, Inc. (CHTP) 5/23/2014
BioAlliance Pharma, TopoTarget A/S To Merge, Combined Entity To Be Named Onxeo 5/22/2014
Clarification Regarding Pfizer Inc. (PFE) Statement 5/21/2014
AstraZeneca PLC (AZN) Rejects Pfizer Inc. (PFE)'s Final Offer 5/20/2014
Endo Completes Acquisition Of Rights To Sumavel® DosePro® 5/19/2014
Boston Scientific Corporation (BSX) Pays $415 Million For Bayer AG (BAYZF) Unit 5/19/2014
Abbott Laboratories (ABT) Expands Latin American Presence And Branded Generics Portfolio With Acquisition Of CFR Pharmaceuticals 5/16/2014
Pfizer Inc. (PFE) Exec Claims AstraZeneca PLC (AZN) Deal Will Not Put Lives At Risk 5/15/2014
AstraZeneca PLC (AZN) Leaves Door Ajar To Pfizer Inc. (PFE), Despite Hurdles 5/15/2014
Eurofins Shells Out $255 Million For U.S. Diagnostic Testing Company 5/14/2014
Origin Agritech Limited (SEED) Announces Receipt Of Acquisition Proposal 5/13/2014
Pfizer Inc. (PFE) Presses AstraZeneca PLC (AZN) Case As CEO Faces UK Grilling 5/13/2014
Shire Pharmaceuticals (SHPG) To Acquire Lumena Pharmaceuticals For Upfront Payment Of $260 Million In Cash 5/13/2014



//-->